Roche Holding AG (CHIX:ROZ) FFO


CHIX:ROZ Roche Holding AG CHIX:ROZ
77 GF Score
Price CHF343.00
GF Value CHF271.62
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:ROZ
77GF Score
Roche Holding AG CHIX:ROZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (CHIX:ROZ) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF343.00 is trading 26.3% above its estimated GF Value™ of CHF271.62. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for CHIX:ROZ:

  • FFO:
  • GF Value™: CHF271.62 vs. price of CHF343.00 (26.3% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the CHIX:ROZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
77GF Score

Get the complete analysis for CHIX:ROZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF343.00
Price
CHF271.62
GF Value